Curatis Holding AGXSWX:CURN +3.51%33 Days Payable is 101.16 as of Dec. 2025, which is 54% above its 10-year median of 65.64. GuruFocus rates XSWX:CURN with a GF Score™ of 33/100. The stock has 7 warning signs investors should review. Among 922 Drug Manufacturers companies, Curatis Holding AG ranks better than 51.08% on this metric.
The historical rank and industry rank for Curatis Holding AG's Days Payable or its related term are showing as below:
XSWX:CURN'
s Days Payable Range Over the Past 10 Years
Min: 55.06 Med: 65.64 Max: 91.78
Current: 91.78
During the past 5 years, Curatis Holding AG's highest Days Payable was 91.78. The lowest was 55.06. And the median was 65.64.
XSWX:CURN's Days Payable is ranked better than 51.08% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs XSWX:CURN: 91.78
Curatis Holding AG's Days Payable
increased
from Dec. 2024 (64.37) to Dec. 2025 (101.16).
It may suggest that Curatis Holding AGdelayed paying its suppliers.
Curatis Holding AG Days Payable Related Terms
Curatis Holding AG Days Payable Historical Data
* Premium members only.
The historical data trend for Curatis Holding AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:CURN vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curatis Holding AG Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's Days Payable distribution charts can be found below:
* The bar in red indicates where Curatis Holding AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Curatis Holding AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curatis Holding AG (XSWX:CURN) has a Days Payable of 101.16 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Curatis Holding AG and its competitors. This is 54% above median its historical median of 65.64. Over the past decade, Curatis Holding AG's Days Payable has ranged from 55.06 to 91.78. According to the industry distribution chart, Curatis Holding AG ranks #451 out of 922 companies in the Drug Manufacturers industry, placing it in the top 48.9%.
Is Curatis Holding AG's Days Payable too high?
Curatis Holding AG's current Days Payable of 101.16 is 54% above median its 10-year median of 65.64. Over the past 10 years, this metric has ranged from a low of 55.06 to a high of 91.78. The Drug Manufacturers industry median Days Payable is 90.84. Curatis Holding AG's value of 101.16 is 11.4% above this industry median. Based on the distribution chart, Curatis Holding AG ranks #451 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Curatis Holding AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Curatis Holding AG's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Curatis Holding AG ranks #451 out of 922 companies for Days Payable. This puts Curatis Holding AG in the upper half of its industry. The industry median Days Payable is 90.84. Curatis Holding AG's value of 101.16 is 11.4% above this benchmark. Historically, Curatis Holding AG's own Days Payable has ranged from 55.06 to 91.78 over the past decade. While the company's 10-year median is 65.64 vs. the industry median of 90.84, Curatis Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Curatis Holding AG's current Days Payable of 101.16 is 11.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Curatis Holding AG and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curatis Holding AG's current Days Payable is 101.16, which is 54% above median its own 10-year median of 65.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curatis Holding AG stock overvalued right now?
Curatis Holding AG (XSWX:CURN) has a current Days Payable of 101.16. The current Days Payable is 101.16, which is 54% above median its 10-year median of 65.64 and 11.4% above the Drug Manufacturers industry median of 90.84. Curatis Holding AG's overall GF Score™ is 33/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Curatis Holding AG (XSWX:CURN), the current Days Payable is 101.16 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Curatis Holding AG is a specialty pharmaceutical Company with two-pillar. On one hand, the Company trades and distributes specialty medicines in the rare disease and specialty medicines space i.e. acquires, licenses, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and specialty diseases in Switzerland. On the other hand, it is a drug development Company with a pipeline of product candidates, also predominantly in the orphan drug space.
33GF Score
Get the complete analysis for XSWX:CURN
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:CURN has been successfully added to your 
